Diagnostic and Therapeutic Efficacy and Safety of Enteroscopy in Pediatric Patients
1 other identifier
observational
208
1 country
1
Brief Summary
The aim of our study was to compare the utility and safety of SBE and DBE in pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedFirst Submitted
Initial submission to the registry
February 8, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedFebruary 13, 2026
January 1, 2026
9.4 years
February 8, 2026
February 8, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
diagnostic yield
Diagnostic yield was defined as the percentage of procedures with a disease-specific definitive endoscopic diagnosis.
From Baseline to the finish of enteroscopy
Secondary Outcomes (5)
Positive rate
from baseline to the finish of enterscopy
Complete enteroscopy
start to the finish of the enteroscopy
Therapeutic yield
frome baselin to finish of the enteroscopy
procedure time
from start to finish of the enteroscopy
adverse events
From first day until 30 days
Study Arms (2)
SBE group
DBE group
Interventions
one group use single-balloon enteroscopy (SBE) in pediatric patients
Eligibility Criteria
pediatric patients (≤18 years) with suspected small bowel disease who underwent BAE
You may qualify if:
- This study retrospectively collected clinical data and endoscopic information of pediatric patients (≤18 years) with suspected small bowel disease who underwent BAE consecutively at a tertiary medical center (Qilu Hospital of Shandong University, Jinan, China) from January 2015 to May 2024.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Qilu Hospital Gastroenterology Department
Study Record Dates
First Submitted
February 8, 2026
First Posted
February 13, 2026
Study Start
January 1, 2015
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
February 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share